Minimally important difference and responsiveness of the MD Anderson Symptom Inventory in evaluating symptom severity and interference in cancer patients

被引：0
|
作者：
Mendoza, Tito [1 ]
Eton, David [2 ]
Yost, Kathleen [2 ]
Novotny, Paul [2 ]
Dueck, Amylou [3 ]
Beebe, Timothy [4 ]
Frost, Marlene [5 ]
Williams, Loretta [1 ]
Cleeland, Charles [1 ]
Sloan, Jeff [2 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Mayo Clin, Rochester, MN USA
[3] Mayo Clin, Scottsdale, AZ USA
[4] Univ Minnesota, Minneapolis, MN USA
[5] Mayo Clin, Minneapolis, MN USA
来源：
QUALITY OF LIFE RESEARCH | 2018年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
3055
引用
收藏
页码：S165 / S165
页数：1
相关论文
共 50 条
  • [1] Understanding and acceptability of the MD Anderson Symptom Inventory in patients with cancer
    Whisenant, Meagan
    Williams, Loretta A.
    Shi, Qiuling
    Mendoza, Tito
    Wang, Xin Shelley
    Cleeland, Charles S.
    [J]. QUALITY OF LIFE RESEARCH, 2019, 28 : S140 - S141
  • [2] Evaluation of the psychometric properties and minimally important difference of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM)
    Mendoza, Tito R.
    Williams, Loretta A.
    Keating, Karen N.
    Siegel, Jonathan
    Elbi, Cem
    Nowak, Anna K.
    Hassan, Raffit
    Cuffel, Brian
    Cleeland, Charles S.
    [J]. JOURNAL OF PATIENT-REPORTED OUTCOMES, 2019, 3 (01)
  • [3] Evaluation of the psychometric properties and minimally important difference of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM)
    Tito R. Mendoza
    Loretta A. Williams
    Karen N. Keating
    Jonathan Siegel
    Cem Elbi
    Anna K. Nowak
    Raffit Hassan
    Brian Cuffel
    Charles S. Cleeland
    [J]. Journal of Patient-Reported Outcomes, 3
  • [4] Determining meaningful cutpoints for the interference items of the MD Anderson Symptom Inventory
    Shi, Qiuling
    Mendoza, Tito
    Wang, Xin Shelley
    Cleeland, Charles S.
    [J]. QUALITY OF LIFE RESEARCH, 2015, 24 : 48 - 48
  • [5] Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory
    Mendoza, Tito
    Sheshadri, Ajay
    Altan, Mehmet
    Hess, Kenneth
    George, Goldy
    Stephen, Bettzy
    Castillo, Lilibeth
    Rodriguez, Enedelia
    Gong, Jing
    Peterson, Christine
    Rodon Ahnert, Jordi
    Fu, Siqing
    Piha-Paul, Sarina A.
    Pant, Shubham
    Dumbrava, Ecaterina
    Yap, Timonthy A.
    Janku, Filip
    Tsimberidou, Apostolia M.
    Subbiah, Vivek
    Karp, Daniel D.
    Zarifa, Abdulrazzak
    McQuinn, Lacey M.
    Cleeland, Charles
    Hong, David S.
    Naing, Aung
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [6] Understanding of the MD Anderson Symptom Inventory (MDASI) by adolescents with cancer
    Williams, Loretta A.
    Robert, Rhonda
    Mauricio, Riza
    Whisenant, Meagan
    Gonzalez, Araceli Garcia
    Cleeland, Charles
    [J]. QUALITY OF LIFE RESEARCH, 2019, 28 : S107 - S108
  • [7] Portuguese validation of the Symptom Inventory of the MD Anderson Cancer Center
    Bernat Kolankiewicz, Adriane Cristina
    Lopes De Domenico, Edvane Birelo
    Dias Lopes, Luis Felipe
    Bosi de Souza Magnago, Tania Solange
    [J]. REVISTA DA ESCOLA DE ENFERMAGEM DA USP, 2014, 48 (06) : 998 - 1003
  • [8] Measuring symptom burden in geriatric oncology with MD Anderson Symptom Inventory (MDASI) in Chinese cancer patients and survivors
    Wang, Xin Shelley
    Shi, Qiuling
    Xue, Dong
    Cleeland, Charles
    Chen, Tsun Hsuan
    Li, Pingping
    [J]. QUALITY OF LIFE RESEARCH, 2019, 28 : S135 - S136
  • [9] Comparative responsiveness and minimally important difference of Fatigue Symptom Inventory (FSI) scales and the FSI-3 in trials with cancer survivors
    Mosher, Catherine E.
    Secinti, Ekin
    Johns, Shelley A.
    Kroenke, Kurt
    Rogers, Laura Q.
    [J]. JOURNAL OF PATIENT-REPORTED OUTCOMES, 2022, 6 (01)
  • [10] Comparative responsiveness and minimally important difference of Fatigue Symptom Inventory (FSI) scales and the FSI-3 in trials with cancer survivors
    Catherine E. Mosher
    Ekin Secinti
    Shelley A. Johns
    Kurt Kroenke
    Laura Q. Rogers
    [J]. Journal of Patient-Reported Outcomes, 6
12345